J.A. van Dongen

3.4k total citations · 1 hit paper
36 papers, 2.6k citations indexed

About

J.A. van Dongen is a scholar working on Oncology, Cancer Research and Pathology and Forensic Medicine. According to data from OpenAlex, J.A. van Dongen has authored 36 papers receiving a total of 2.6k indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Oncology, 17 papers in Cancer Research and 8 papers in Pathology and Forensic Medicine. Recurrent topics in J.A. van Dongen's work include Breast Cancer Treatment Studies (15 papers), Cutaneous Melanoma Detection and Management (11 papers) and Breast Lesions and Carcinomas (7 papers). J.A. van Dongen is often cited by papers focused on Breast Cancer Treatment Studies (15 papers), Cutaneous Melanoma Detection and Management (11 papers) and Breast Lesions and Carcinomas (7 papers). J.A. van Dongen collaborates with scholars based in Netherlands, Belgium and United Kingdom. J.A. van Dongen's co-authors include Harry Bartelink, Johannes L. Peterse, Richard Sylvester, M Blichert-Toft, Geertjan van Tienhoven, Knud Andersen, Adri C. Voogd, Jacques Borger, Maja Nielsen and Marie Overgaard and has published in prestigious journals such as The Lancet, Journal of Clinical Oncology and JNCI Journal of the National Cancer Institute.

In The Last Decade

J.A. van Dongen

35 papers receiving 2.5k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Long-Term Results of a Randomized Trial Comparing Breast-Conserving Therapy With Mastectomy: European Organization for Research and Treatment of Cancer 10801 Trial

2000 975 citations J.A. van Dongen JNCI Journal of the National Cancer Institute profile →

Peers

Countries citing papers authored by J.A. van Dongen

Since Specialization

Citations

This map shows the geographic impact of J.A. van Dongen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J.A. van Dongen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J.A. van Dongen more than expected).

Fields of papers citing papers by J.A. van Dongen

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by J.A. van Dongen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J.A. van Dongen. The network helps show where J.A. van Dongen may publish in the future.

Co-authorship network of co-authors of J.A. van Dongen

This figure shows the co-authorship network connecting the top 25 collaborators of J.A. van Dongen. A scholar is included among the top collaborators of J.A. van Dongen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with J.A. van Dongen. J.A. van Dongen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Surgical oncology in Europe 2004 ·Nowotwory Journal of Oncology ·J.A. van Dongen	1
2	Differences in Risk Factors for Local and Distant Recurrence After Breast-Conserving Therapy or Mastectomy for Stage I and II Breast Cancer: Pooled Results of Two Large European Randomized Trials 2001 ·Journal of Clinical Oncology ·Adri C. Voogd, Maja Nielsen, Johannes L. Peterse, M Blichert-Toft, Harry Bartelink, Marie Overgaard, Geertjan van Tienhoven, Knud Andersen, Richard Sylvester, J.A. van Dongen	423
3	Long-Term Results of a Randomized Trial Comparing Breast-Conserving Therapy With Mastectomy: European Organization for Research and Treatment of Cancer 10801 Trial breakdown → 2000 ·JNCI Journal of the National Cancer Institute ·J.A. van Dongen	975
4	Low risk of locoregional recurrence of primary breast carcinoma after treatment with a modification of the Halsted radical mastectomy and selective use of radiotherapy 1999 ·Cancer ·Nina Bijker, Emiel J. Rutgers, Johannes L. Peterse, J.A. van Dongen, (unknown), Jacques Borger, Bin B. R. Kroon	2
5	Low risk of locoregional recurrence of primary breast carcinoma after treatment with a modification of the Halsted radical mastectomy and selective use of radiotherapy 1999 ·Cancer ·Nina Bijker, Emiel J. Rutgers, Johannes L. Peterse, J.A. van Dongen, (unknown), Jacques Borger, Bin B. R. Kroon	20
6	Prognosis after treatment for loco-regional recurrence after mastectomy or breast conserving therapy in two randomised trials (EORTC 10801 and DBCG-82TM) 1999 ·European Journal of Cancer ·Geertjan van Tienhoven, Adri C. Voogd, Johannes L. Peterse, Michael Bachmann Nielsen, Knud Andersen, F Mignolet, Richard Sylvester, Ian S. Fentiman, Emmanuel van der Schueren, (unknown), M Blichert-Toft, Harry Bartelink, J.A. van Dongen	148
7	Cancer screening in the elderly 1998 ·European Journal of Surgical Oncology ·J.A. van Dongen	1
8	Value of laboratory tests in monitoring acute regional toxicity after isolated limb perfusion 1997 ·Annals of Surgical Oncology ·Bart C. Vrouenraets, (unknown), Joost M. Klaase, J. M. G. Bonfrer, Omgo E. Nieweg, Gooike W. van Slooten, J.A. van Dongen	21
9	Physiological Implications of Hyperbaric Oxygen Tensions in Isolated Limb Perfusion using Melphalan: A Pilot Study 1996 ·European Surgical Research ·B. C. Vrouenraets, B.B.R. Kroon, (unknown), Joost M. Klaase, (unknown), Gooike W. van Slooten, Omgo E. Nieweg, Jacoba van der Zee, J.A. van Dongen	7
10	Systemic toxicity after isolated limb perfusion with melphalan for melanoma 1996 ·European Journal of Surgical Oncology ·(unknown), Bart C. Vrouenraets, Bert N. van Geel, (unknown), Joost M. Klaase, Omgo E. Nieweg, J.A. van Dongen, Bin B. R. Kroon	30
11	Should tamoxifen be a primary treatment choice for elderly breast cancer patients with locoregional disease? 1995 ·Breast Cancer Research and Treatment ·Liesbeth Bergman, J.A. van Dongen, B van Ooijen, Flora E. van Leeuwen	42
12	The prognostic significance of the axillary apex biopsy in clinically operable breast cancer 1995 ·European Journal of Cancer ·Geertjan van Tienhoven, Jacques Borger, (unknown), A. A. M. Hart, Emiel J. Rutgers, J.A. van Dongen, Harry Bartelink	14
13	Melphalan tissue concentrations in patients treated with regional isolated perfusion for melanoma of the lower limb 1994 ·British Journal of Cancer ·(unknown), B.B.R. Kroon, J. H. Beijnen, Gooike W. van Slooten, J.A. van Dongen	38
14	Comparison Between the Use of Whole Blood Versus a Diluted Perfusate in Regional Isolated Perfusion by Continuous Monitoring of Transcutaneous Oxygen Tension: A Pilot Study 1994 ·Journal of Investigative Surgery ·Joost M. Klaase, B.B.R. Kroon, Gooike W. van Slooten, J.A. van Dongen, (unknown), Jacoba van der Zee	7
15	Regional Isolated Limb Perfusion in Patients with Malignant Melanoma 1993 ·Oncology Research and Treatment ·B. C. Vrouenraets, Joost M. Klaase, A.N. van Geel, A.M.M. Eggermont, (unknown), (unknown), J.A. van Dongen, B.B.R. Kroon	8
16	Clinical heterogeneity of hereditary breast cancer and its impact on screening protocols: The dutch experience on 24 families under surveillance 1993 ·European Journal of Cancer ·Hans F. A. Vasen, L.V.A.M. Beex, F. J. Cleton, H.J.A. Collette, J.A. van Dongen, Flora E. van Leeuwen, M.A. Crommelin, P. Meera Khan	9
17	Results of a double perfusion schedule with melphalan in patients with melanoma of the lower limb 1993 ·European Journal of Cancer ·Bin B. R. Kroon, Joost M. Klaase, Bert N. van Geel, (unknown), (unknown), J.A. van Dongen	27
18	Quality assurance in cancer treatment 1993 ·European Journal of Cancer ·Emmanuel van der Schueren, Jean-Claude Horiot, G. Leunens, R.D. Rubens, William P. Steward, J.A. van Dongen, A.T. van Oosterom, K. Vantongelen	32
19	The role of regional isolated perfusion in the eradication of melanoma micrometastases in the inguinal nodes 1992 ·Melanoma Research ·Joost M. Klaase, B.B.R. Kroon, A.N. van Geel, Alexander Eggermont, H. R. Franklin, J.A. van Dongen	3
20	The Impact of tumor size and histology on local control after breast-conserving therapy 1988 ·Radiotherapy and Oncology ·Harry Bartelink, Jacques Borger, J.A. van Dongen, Johannes L. Peterse	186

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact